INGN  valuation analysis

Basics
Name: Inogen, Inc
Description: Inogen, Inc., a medical technology company, primarily develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. (more)
Industry: Medical Devices
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Feb 24, 2021
Market cap: $1.39B (1167th)
Sales(TTM): $308.49M (1302nd)
Earnings(TTM): -$5.83M (1067th)

Value
FFER: 0.75 (why)
Actual price: $62.70
FFEThis is Inogen, Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $63.23
Quantile: INGN is cheap given its fundamentals.
Prices as of EOD 2021-04-14
Price & Estimates
Sales & Earnings history (TTM)
Notable
  • Inogen, Inc's earnings decreased from $20.95M to -$5.83M in the last year.
  • Inogen, Inc's operating income decreased from $19.79M to -$12.03M in the last year.
Earnings / MarketCap
Inogen, Inc
"Medical Devices" industry
Sales / MarketCap
Inogen, Inc
"Medical Devices" industry
Book / MarketCap
Inogen, Inc
"Medical Devices" industry
Equity / Assets
Inogen, Inc
"Medical Devices" industry